Concepts (58)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Muscular Atrophy, Spinal | 1 | 2020 | 4 | 0.720 |
Why?
|
Oligonucleotides | 1 | 2020 | 30 | 0.700 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 104 | 0.660 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 918 | 0.420 |
Why?
|
Silicone Oils | 2 | 2021 | 10 | 0.370 |
Why?
|
Vitreous Body | 1 | 2021 | 10 | 0.190 |
Why?
|
Leukoencephalopathies | 1 | 2020 | 12 | 0.180 |
Why?
|
Fluoroscopy | 1 | 2020 | 40 | 0.180 |
Why?
|
Injections, Spinal | 1 | 2020 | 108 | 0.180 |
Why?
|
Radiography, Dual-Energy Scanned Projection | 1 | 2018 | 5 | 0.160 |
Why?
|
Practice Management, Medical | 1 | 2018 | 8 | 0.160 |
Why?
|
Coronavirus Infections | 1 | 2020 | 98 | 0.160 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 102 | 0.160 |
Why?
|
Brain | 2 | 2020 | 951 | 0.150 |
Why?
|
Child, Preschool | 2 | 2020 | 1269 | 0.150 |
Why?
|
Infant | 1 | 2020 | 1061 | 0.140 |
Why?
|
Young Adult | 2 | 2021 | 2636 | 0.140 |
Why?
|
Retrospective Studies | 2 | 2021 | 3509 | 0.130 |
Why?
|
Middle Aged | 4 | 2021 | 11817 | 0.110 |
Why?
|
Child | 1 | 2020 | 2438 | 0.110 |
Why?
|
Adolescent | 1 | 2020 | 3539 | 0.100 |
Why?
|
Adult | 3 | 2021 | 9345 | 0.100 |
Why?
|
Male | 5 | 2021 | 19165 | 0.100 |
Why?
|
Pharyngitis | 1 | 2010 | 10 | 0.090 |
Why?
|
Streptococcus pyogenes | 1 | 2010 | 16 | 0.090 |
Why?
|
Streptococcal Infections | 1 | 2010 | 22 | 0.090 |
Why?
|
Jugular Veins | 1 | 2010 | 26 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2010 | 49 | 0.090 |
Why?
|
Humans | 7 | 2021 | 32005 | 0.090 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 2008 | 8 | 0.080 |
Why?
|
Spin Labels | 1 | 2008 | 24 | 0.080 |
Why?
|
Cerebral Arteries | 1 | 2008 | 18 | 0.080 |
Why?
|
Cerebral Infarction | 1 | 2008 | 22 | 0.080 |
Why?
|
Magnetic Resonance Angiography | 1 | 2008 | 77 | 0.080 |
Why?
|
Female | 3 | 2021 | 19959 | 0.070 |
Why?
|
Technology, Pharmaceutical | 1 | 2003 | 3 | 0.060 |
Why?
|
Captopril | 1 | 2003 | 8 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 517 | 0.060 |
Why?
|
Corpus Callosum | 1 | 2020 | 18 | 0.040 |
Why?
|
Retinal Detachment | 1 | 2020 | 9 | 0.040 |
Why?
|
Hemorrhage | 1 | 2020 | 100 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 112 | 0.040 |
Why?
|
Workflow | 1 | 2018 | 21 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2018 | 38 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2021 | 762 | 0.040 |
Why?
|
Software | 1 | 2018 | 123 | 0.040 |
Why?
|
Decision Making | 1 | 2018 | 195 | 0.030 |
Why?
|
Clinical Competence | 1 | 2018 | 333 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2021 | 3990 | 0.030 |
Why?
|
Syndrome | 1 | 2010 | 72 | 0.020 |
Why?
|
Aged | 1 | 2021 | 10301 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 93 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2008 | 181 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2008 | 411 | 0.010 |
Why?
|
Dosage Forms | 1 | 2003 | 4 | 0.010 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2003 | 11 | 0.010 |
Why?
|
Administration, Oral | 1 | 2003 | 187 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2008 | 2265 | 0.010 |
Why?
|